AaronKoenigMD

Psychiatry • Wellesley, MA

Geriatric Psychiatry, Pain Medicine

Physician

Join to view full profile

Are you Dr. Koenig?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
178 Oakland St
Wellesley, MA 02481
Phone+1 301-356-4114

Fax+1 617-726-5760

Summary

Dr. Aaron Koenig, MD is a board certified psychiatrist in Wellesley, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania.

Education & Training

University of Pennsylvania Health SystemFellowship, Geriatric Psychiatry, 2014 - 2015
UPMC Medical EducationResidency, Psychiatry, 2010 - 2014
Perelman School of Medicine at the University of PennsylvaniaClass of 2010

Certifications & Licensure

MA State Medical License 2015 - 2026
PA State Medical License 2013 - 2018
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Geriatric Psychiatry

Clinical Trials

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI) Start of enrollment: 2020 Jul 31
Completed
Phase 2

Publications & Presentations

PubMed

12 citations
CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Alan J Lerner, Steven E Arnold, Erin Maxfield, Aaron Koenig, Maria E Toth
Alzheimer's Research & Therapy. 2022-12-29
7 citations
Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults.
Victoria J. Williams, Bianca A. Trombetta, Rabab Z. Jafri, Aaron M. Koenig, Chase D Wennick
JCI Insight. 2019-07-25
10 citations
Biomarkers in Alzheimer’s, Frontotemporal, Lewy Body, and Vascular Dementias
Aaron M. Koenig, Chloe K. Nobuhara, Victoria J. Williams, Steven E. Arnold
Focus. 2018-04-27

Press Mentions

Delix Presents Full Results from Phase 1 Trial of DLX-001 at ACNP Annual MeetingDecember 12th, 2024
American Academy of Neurology, April 2-7April 20th, 2022
Preliminary Study: Drug May Be Safe in Those with Mild Cognitive Impairment, Mild DementiaMarch 31st, 2022
Join now to see all